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Abstract
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological 
entity presented with different symptoms such as visual disturbances, headaches, 
seizures, severe hypertension and altered mental status. It has been recognized in 
a different pathological conditions, although preeclampsia/eclampsia is the most 
common cause of PRES. The pathogenesis of PRES is still not fully understood, but 
it seems that failure of cerebrovascular autoregulation causing vasogenic edema, 
cerebral vasoconstriction, and disruption of the blood brain barrier plays an 
important role. Cortical blindness, hypertensive retinopathy, serous retinal detach-
ment (SRD), central retinal artery and vein occlusions, retinal or vitreous hemor-
rhages, anterior ischemic optic neuropathy (AION) and Purtscher’s retinopathy are 
ophthalmic disorders that may occur in PRES associated with preeclampsia. Among 
these, cortical blindness is the best documented complication of preeclampsia. 
Magnet resonance imaging (MRI) is a gold standard to establish the diagnosis of 
PRES because clinical findings are not sufficiently specific. Typically, there are 
bilateral cortical occipital lesions with hyperdensity on T2-weighted MRI. Blindness 
due to occipital lesions is reversible and the vision loss is usually regained within 4 h 
to 8 days.
Keywords: preeclampsia, eclampsia, posterior reversible encephalopathy syndrome, 
ophthalmological disorders, cortical blindness
1. Introduction
Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiologi-
cal entity presented with different symptoms, such as headaches, seizures, visual 
disturbances, severe hypertension, and altered mental status [1]. Previously, it has 
been known by various names such as reversible posterior leukoencephalopathy 
syndrome, reversible posterior cerebral edema syndrome, and reversible occipital 
parietal encephalopathy [2, 3]. PRES was first described in 1996 by Hinchey et al. 
in patients with acute neurological symptoms and since then it has been recognized 
in different pathological conditions such as preeclampsia, eclampsia, hypertensive 
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encephalopathy, autoimmune diseases, renal failure, infection, and the use of 
cytotoxic or immunosuppressive drugs [1, 3–9]. Among these, preeclampsia and 
eclampsia are the most common causes of PRES. Preeclampsia is pregnancy-specific 
disorder clinically characterized by a new onset of hypertension and proteinuria 
that appear after the 20th week of gestation and up to 6 weeks postpartum in 
a previously normotensive woman [5, 6]. Preeclampsia and its variants affect 
approximately 5% of pregnancies and is the leading cause of both maternal and 
fetal morbidity and mortality worldwide [10]. It is characterized by impaired organ 
perfusion that occurs as a result of vasospasm and activation of the coagulation 
system [11]. Eclampsia is an acute cerebral complication of preeclampsia, presented 
with the occurrence of tonic-clonic convulsions in pregnant or recently postpartum 
women [12]. Severe intracranial vasospasm, local ischemia, intracranial hyperten-
sion, and endothelial dysfunction associated with vasogenic and cytotoxic edema 
are possible causes of seizures in PRES [11]. Rare cases of PRES in pregnant women 
with normal blood pressure and without preeclampsia have also been described in 
the literature [13]. Early recognition of PRES is essential in order to timely apply the 
medication, which typically includes drugs that lower blood pressure, act as anti-
edematous and interrupt tonic-clonic convulsions [7].
2. Pathogenesis of PRES
The exact pathophysiological mechanisms of PRES are not precisely known. 
Failure of cerebrovascular autoregulation, cerebral vasoconstriction, and disruption 
of the blood brain barrier due to endothelial disfunction are possible mechanisms 
involved in the pathogenesis of PRES [2]. Failure of cerebrovascular autoregulation 
causing vasogenic edema is the most accepted one. It seems that hyperperfusion 
plays a crucial role in disorders where hypertension is a key feature, such as in 
preeclampsia [14]. During fluctuations of systemic blood pressure, cerebrovascu-
lar autoregulation maintains cerebral blood flow, leading to vasodilation during 
systemic hypotension and vasoconstriction during systemic hypertension. The rapid 
development of hypertension can exceed the capacity of cerebral blood flow auto-
regulation leading to hyperperfusion [14]. It is supposed that posterior brain regions 
are more vulnerable to hyperperfusion, which is explained by better autoregulation 
of the anterior circulation due to better sympathetic innervations as compared to 
the posterior circulation [15]. Another theory suggests spasm of cerebral arter-
ies in response to acute hypertension, thus resulting in decreased cerebral blood 
flow, intraarterial thrombosis, and cerebral ischemia leading to cytotoxic edema, 
especially in the border zones between arterial territories [16–18]. Breakdown of the 
blood brain barrier and endothelial dysfunction occurs in PRES with fluid and mac-
romolecule extravasation into the interstitium. Further, increased concentrations 
of circulating cytokines activate endothelial cells and allow adhesion of circulat-
ing leukocytes. On the other hand, the tight junctions are disrupted and vascular 
endothelial growth factor expression is increased, leading to increased vascular 
permeability and vasogenic edema [19].
3. Neuroimaging features of PRES
The diagnosis of PRES cannot be established exclusively on clinical findings 
[1]. Brain lesions are usually located in the white matter, although rarely, overlying 
cortex may also be affected [20]. The parieto-occipital regions of the brain are main 
foci of changes, that are usually bilateral and symmetric. However, the lesions can 
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also extend to other brain structures such as the frontal and temporal lobes, cerebel-
lar hemispheres, basal ganglia, brain stem, and deep white matter [21]. A multislice 
computed tomography (MSCT) scan is often normal or shows cortical-subcortical 
hypodensities, predominantly in posterior brain regions. However, MSCT scans in 
PRES show lesions in only of about 50% cases [22]. Because of that, magnet reso-
nance imaging (MRI) is a gold standard for the diagnosis of PRES and the follow-up 
of these patients. Neuroimaging studies showed hypointense or isointense signal 
changes on T1-weighted images. The typical neuroimaging feature is a high signal 
intensity on T2-weighted images predominantly in the posterior regions, which 
is caused by subcortical white matter vasogenic edema [1]. Abnormalities are 
more observable on fluid-attenuated inversion recovery imaging (FLAIR), which 
increases the ability to detect subtle lesions in PRES [15]. Supplemental diffusion-
weighted imaging (DWI) and apparent diffusion coefficient (ADC) map images 
are helpful in distinguishing vasogenic oedema from cytotoxic edema [15–19]. 
Cytotoxic edema appears hyperintense on DWI with a low signal intensity image on 
the corresponding ADC sequence. A predominantly low signal on DWI and a high 
signal on ADC image indicates vasogenic edema. Vasogenic edema and cytotoxic 
edema can also coexist in eclampsia [23].
4. Ocular disorders in PRES associated with preeclampsia
Visual disorders in pregnancy can be highly variable and range from mild 
symptoms such as transient blurred vision, photopsia, and different types of 
visual field defects to transient or permanent total blindness [24]. Vision loss 
during pregnancy has been documented in 1–3% of cases and a possible causes 
are cortical blindness, central retinal artery and vein occlusions, retinal detach-
ment, ischemic optic neuropathy, retinal or vitreous hemorrhages, and Purtscher’s 
retinopathy [24–26]. Approximately 25% patients with severe preeclampsia and 
50% patients with eclampsia present different visual symptoms including blurred 
vision, homonymous hemianopsia, visual neglect, visual anosognosia, and cortical 
blindness [27, 28]. They seem to be a consequence of the cerebral edema located 
in the occipital cortex or in the temporal and parietal association cortices. In most 
patients, the visual impairment is reversible, but in rare cases, permanent blind-
ness has been described [29].
4.1 Cortical blindness
Cortical blindness is among the best-documented complications of preeclamp-
sia/eclampsia and affects almost 15% of eclamptic women [30, 31]. Cortical 
blindness is caused by a dysfunction in the visual pathway that conducts visual 
information from the lateral geniculate nucleus of the thalamus to the cerebral 
visual cortex [20]. Vasogenic edema is the main cause of cortical blindness. It 
appears that the primary visual cortex in the occipital lobes is more susceptible 
to the breakdown of cerebrovascular autoregulation and subsequent hyperperfu-
sion than other brain regions [31]. Cortical blindness has been described to occur 
several hours before or after eclamptic seizures, rarely several days or weeks 
postpartum [32–34]. The bilateral vision loss often begins with blurry vision and 
progresses within a couple of hours to bare light perception [35]. Sometimes, the 
woman is unaware of her blindness and feels that she can see, which is known 
as visual anosognosia or Anton syndrome, indicating involvement of the visual 
association cortex [34, 36]. However, cortical blindness is associated with an intact 
pathway from the eye to the lateral geniculate body and therefore ophthalmological 
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examination including the pupillary reflexes, ocular motility, and fundoscopic find-
ings is normal in these patients [29]. Blindness due to occipital lesions is reversible 
and the vision loss is usually regained within 4 h to 8 days [27].
5. Other ocular disorders in pregnancy complicated with preeclampsia
5.1 Hypertensive retinopathy
According to some studies, the prevalence rate of hypertensive retinopathy 
in women with hypertensive disorders in pregnancy is 32.5% [37]. Generally, the 
retinal vascular changes correlate with the severity of systemic hypertension. At the 
pathophysiological level, increased blood pressure leads to focal or diffuse vaso-
constriction. In addition, increased vascular permeability leads to the extravasation 
of fluid to the extravascular spaces. Clinically, the most common abnormality seen 
during fundoscopy is narrowing of retinal arterioles [38]. Other retinal changes 
that may be present are decreased retinal artery to vein ratio, cotton wool spots, 
hemorrhages and Elschnig spots [39]. Vasospastic manifestations are reversible, and 
the retinal vessels rapidly return to normal after delivery [38].
5.2 Serous retinal detachment
Serous retinal detachment (SRD) is a rare complication of hypertensive disease 
in pregnancy, affecting 1–2% of preeclamptic and 10% of eclamptic women [40]. 
It is characterized by separation of the neurosensory retina from the pigmented 
retinal epithelium and it is usually observed in the absence of significant retinal 
vascular abnormalities or retinal breaks [41]. It may be present either before or 
after delivery [42]. Clinically, patients report loss of visual acuity and visual field 
defects [42, 43]. The detachments are often bullous and bilateral [27]. The exact 
pathophysiology of SRD in cases of preeclampsia is not well known, but it seems 
to be related with choroidal ischemia, which is secondary to an intensive arteriolar 
vasospasm [27]. The choroidal vascular insufficiency can lead to lesions in retinal 
pigment epithelium, fluid transudation, and focal retinal detachment. The majority 
of women who manifest SRD during pregnancy have a gradually improvement of 
visual acuity in few weeks after delivery, ending with complete recovery of vision 
[31]. Management of SRD in preeclampsia is conservative and involves treating the 
underlying condition [27].
5.3 Purtscher’s retinopathy
Purtscher’s retinopathy is a rare cause of visual loss during pregnancy and 
has been mostly described in association with complicated labor [24]. However, 
isolated cases during normal spontaneous labor have also been described in the 
literature [44]. Clinically, it presents with decreased visual acuity and a different 
types of visual field defects such as central or paracentral scotoma. The retinal 
changes include ischemia at the posterior pole with white patches of edema known 
as Purtscher’s flecken, which represent areas of capillary bed infarction. In the 
initial phase, the optic disc is normal, but in the later phases, disc pallor and optic 
atrophy occur [27]. According to some researchers, these fundoscopic changes 
may be caused by embolic occlusion of the precapillary arterioles of the retina by 
fat, air, platelets, and leukocyte aggregates [45, 46]. The diagnosis is established 
on the basis of clinical findings and confirmed by intravenous fluorescein angiog-
raphy [47]. The majority of patients recover some of their visual function without 
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treatment. Use of systemic steroids may improve visual outcome in some patients, 
but momentary specific medication is not available [47].
5.4 Anterior ischemic optic neuropathy
Anterior ischemic optic neuropathy (AION) is a rare ophthalmological disorder 
in preeclampsia that has been described to occur before and after delivery. Clinically, 
it is presented with sudden vision loss and unilateral or bilateral disc edema [48, 49]. 
The exact pathophysiology of AION in preeclampsia remains unclear, but it is sug-
gested that uncontrolled hypertension leads to vasoconstriction or ischemia in the 
posterior ciliary artery circulation [49].
5.5 Central retinal vein occlusion
Central retinal vein occlusion (CRVO) is also described in preeclamptic 
women and was presented with bilateral vision loss up to 21 days postpartum. 
Ophthalmologic examination reveals multiple retinal hemorrhages in all 4 quad-
rants, venous dilatation, and macular edema. Improvement of visual acuity is 
significant but not complete [31]. The exact pathophysiological mechanism of 
CRVO in preeclampsia is not fully understood; however, it is proposed that central 
retinal artery thickening is thought to cause compression of the central retinal vein, 
thereby leading to venous occlusion [50, 51].
5.6 Central retinal artery occlusion
Central retinal artery occlusion (CRAO) is rare in young people, and it is usually 
associated with a predisposing pathological disorders such as cardiac valvular disease, 
systemic vascular disease, and hypercoagulable disorders. According to some studies, 
CRAO is rarely described in women with eclampsia [52, 53]. Clinically, it is presented 
with sudden, painless, and persistent vision loss. Fundoscopy shows typical changes 
such as pallor of posterior pole with cherry-red spot. It seems that the activation of 
coagulation system could be a cause of multiple emboli and vascular occlusion in 
these patients [53].
5.7 Retinal and vitreous hemorrhages
Retinal and vitreous hemorrhages are rare disorders that may precede the appear-
ance of preeclampsia. They are presented as a sudden vision loss in a normotensive 
pregnant women, who usually develop preeclampsia within 2 weeks after labor [54, 55].
6. Conclusion
Preeclampsia and eclampsia are the most common conditions associated with 
PRES. Due to the high predilection of pathological lesions in white matter of the 
occipital lobes, PRES could be manifested with different types of ocular disorders. 
Some of these complications can be serious including cortical blindness, SRD, 
CRVO, CRAO, AION, and vitreal and retinal hemorrhages. Clinicians should be 
aware of these ocular manifestations, and careful ophthalmological, neurological, 
and neuroradiological evaluation should be carried out to ascertain the various 
causes of vision loss in pregnancy. In most cases, visual prognosis is usually good 
with permanent vision recovery. Effective treatment of preeclampsia/eclampsia 
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